BioCancell Therapeutics Inc (BICL.TA)

Ticker: BICL.TA


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Clal Biotechnology Industries Ltd. Large shareholder
Transaction date
Purchase
Price
252.47
Quantity 45,928 -19.2%
Value US$2,928,871
Clal Biotechnology Industries Ltd. Large shareholder
Transaction date
Purchase
Price
251.86
Quantity 67,902 -41.8%
Value US$3,719,400
Boim Aviv Non-Executive Director Large shareholder
Transaction date
Purchase
Price
476.26
Quantity 52,664 +33.9%
Value US$3,407,217
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2012-08-07 2012-07-31 B Purchase Clal Biotechnology Industries Ltd. Large shareholder
45,928 -19.2%
252.47
US$2,928,871
45,928 -19.2% 252.47 US$2,928,871
2012-03-07 2012-01-24 B Purchase Clal Biotechnology Industries Ltd. Large shareholder
67,902 -41.8%
251.86
US$3,719,400
67,902 -41.8% 251.86 US$3,719,400
2010-08-30 2008-07-31 B Purchase Boim Aviv Non-Executive Director Large shareholder
52,664 +33.9%
476.26
US$3,407,217
52,664 +33.9% 476.26 US$3,407,217
Explore more

More insider trading research around BioCancell Therapeutics Inc